Aims This study aimed to investigate the impact of cardiac resynchronization therapy with a
defibrillator (CRT-D) on mortality, comparing it with CRT with a pacemaker (CRT-P) …

The populations of Asian countries are expected to age rapidly in the near future, with a
dramatic increase in the number of heart failure (HF) patients also anticipated. The need for …

Background Current guidelines did not provide recommendations on indications of an
additional implantable cardioverter‐defibrillator (ICD) to patients receiving cardiac …

Background Panoramic studies in patients with cardiac resynchronization therapy with a
defibrillator (CRT‐D) focusing on the etiology and indication are scarce. Besides, a …

Background Heart failure and reduced ejection fraction (HFrEF) is the predominant
indication for cardiac resynchronization therapy (CRT) and implantable cardioverter …

Background Trends of de novo implantation of cardiac implantable electronic devices
(CIEDs) including implantable cardioverter‐defibrillator (ICD) and cardiac resynchronization …

Aims Cardiac resynchronization therapy (CRT) is an established treatment for drug‐
refractory heart failure (HF) in patients with left bundle branch block (LBBB). Acute …

Background Cardiac resynchronization therapy (CRT)-defibrillator (CRT-D) has been more
widely implanted than CRT-pacemaker (CRT-P) in patients of heart failure with reduced …

One benefit of an implantable cardioverter-defibrillator is the prevention of sudden cardiac
death (SCD). It is recommended for patients with a low left ventricular ejection fraction …

Background: Cardiac resynchronization therapy defibrillator (CRT-D) and pacemaker (CRT-
P) are treatment options for patients with advanced heart failure and electrical dyssynchrony …